Paralytic ileus after planned abdominal surgery in a patient on treatment with erenumab

Intern Emerg Med. 2021 Jan;16(1):227-228. doi: 10.1007/s11739-020-02407-y. Epub 2020 Jun 17.

Authors

Ilaria Frattale¹, Raffaele Ornello², Francesca Pistoia², Valeria Caponnetto², Enrico Colangeli², Simona Sacco²

Affiliations

¹ Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, 67100, L'Aquila, Italy. ilariafrattale@libero.it.
² Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, 67100, L'Aquila, Italy.

PMID: 32557089
DOI: 10.1007/s11739-020-02407-y

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / adverse effects*
Calcitonin Gene-Related Peptide Receptor Antagonists / adverse effects*
Female
Humans
Intestinal Pseudo-Obstruction / chemically induced*
Migraine Disorders / drug therapy*
Postoperative Period
Uterine Neoplasms / surgery*

Substances

Antibodies, Monoclonal, Humanized
Calcitonin Gene-Related Peptide Receptor Antagonists
erenumab